Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Neoplasm Metastasis 2Sarcoma, Synovial 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Rectal Neoplasms 1Osteosarcoma 1Neuroblastoma 1Neoplasms 1Myelodysplastic Syndromes 1Melanoma 1Liposarcoma, Myxoid 1Graft vs Host Disease 1Colonic Neoplasms 1Carcinoma, Merkel Cell 1

Interventions

Ifosfamide 6Leucovorin 5Doxorubicin 4Dexrazoxane 4Cisplatin 4Methotrexate 3Filgrastim 3Carboplatin 3mifamurtide 2glucarpidase 2Radiotherapy 2Neoadjuvant Therapy 2Mesna 2Granulocyte-Macrophage Colony-Stimulating Factor 2Granulocyte Colony-Stimulating Factor 2Gemcitabine 2Cryosurgery 2Chemotherapy, Adjuvant 2temsirolimus 1sintilimab 1sargramostim 1saracatinib 1samarium Sm-153 lexidronam 1robatumumab 1pembrolizumab 1pegfilgrastim 1pazopanib 1omburtamab I-131 1niraparib 1lexatumumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Osteosarcoma × Interferon-gamma × Clear all
NCT00428272 2019-12-17

HGS-ETR2 to Treat Children With Solid Tumors

National Institutes of Health Clinical Center (CC)

Phase 1 Terminated
30 enrolled
CNSSarcoma

Neoplasm Metastasis, Neoplasms, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡